Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
Clinical trial NCT05785442 · COMPLETED
Trial details
- NCT number
- NCT05785442
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2024-06-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.